BOVOLENTA, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 4.472
EU - Europa 1.704
AS - Asia 858
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 3
OC - Oceania 3
Totale 7.062
Nazione #
US - Stati Uniti d'America 4.447
PL - Polonia 564
CN - Cina 397
IT - Italia 311
SG - Singapore 232
DE - Germania 231
UA - Ucraina 173
TR - Turchia 141
GB - Regno Unito 126
SE - Svezia 104
FI - Finlandia 64
ID - Indonesia 43
BE - Belgio 42
CA - Canada 24
FR - Francia 23
BR - Brasile 14
NL - Olanda 14
RU - Federazione Russa 14
VN - Vietnam 14
HK - Hong Kong 13
CZ - Repubblica Ceca 9
IE - Irlanda 9
IN - India 7
EU - Europa 5
CH - Svizzera 4
HR - Croazia 4
ES - Italia 3
LT - Lituania 3
AU - Australia 2
IQ - Iraq 2
IR - Iran 2
RO - Romania 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
CL - Cile 1
DZ - Algeria 1
GL - Groenlandia 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TW - Taiwan 1
Totale 7.062
Città #
Warsaw 564
Woodbridge 554
Fairfield 515
Ann Arbor 386
Houston 327
Chandler 322
Ashburn 253
Jacksonville 218
Santa Clara 217
Seattle 211
Wilmington 200
Singapore 196
Cambridge 174
Ferrara 117
Izmir 96
Nanjing 83
New York 61
Princeton 60
Milan 55
Beijing 53
Shanghai 49
San Diego 48
Boardman 45
Jakarta 41
Munich 38
Bremen 37
Brussels 37
Dearborn 30
Nanchang 23
Falls Church 22
Helsinki 21
Tianjin 20
Los Angeles 19
Shenyang 19
Kunming 16
London 16
Bologna 13
Des Moines 13
Hebei 13
Dong Ket 12
Hong Kong 12
Redwood City 12
Changsha 11
Auburn Hills 10
Jinan 10
Ottawa 10
San Mateo 10
Toronto 10
Washington 10
Brno 8
Mountain View 8
Frankfurt am Main 7
Norwalk 7
Rome 7
Zhengzhou 7
Absecon 6
Addison 6
Hangzhou 6
Guangzhou 5
Hefei 5
Jiaxing 5
Ningbo 5
Parma 5
Dublin 4
Falkenstein 4
Ferrara di Monte Baldo 4
Leawood 4
Leiden 4
Menlo Park 4
Modena 4
Shenzhen 4
Taizhou 4
Augusta 3
Chicago 3
Clifton 3
Evanston 3
Genova 3
Indiana 3
Monmouth Junction 3
Napoli 3
Phoenix 3
Redmond 3
Tappahannock 3
Verona 3
Wuhan 3
Balasore 2
Borgo Val di Taro 2
Brescia 2
Changchun 2
Chengdu 2
Collecorvino 2
Fort Worth 2
Fremont 2
Genoa 2
Guarda Veneta 2
Haikou 2
Hanoi 2
Hasselt 2
Hounslow 2
Lainate 2
Totale 5.481
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 336
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 313
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 307
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 195
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 190
Crispr/Cas9-based COL7A1 editing for recessive dystrophic epidermolysis bullosa 182
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 179
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 169
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 162
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 158
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 157
null 155
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 153
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 152
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 151
Exon skipping-mediated dystrophin reading frame restoration for small mutations 150
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 139
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 136
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 134
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 133
null 131
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 129
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 129
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 122
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 122
Transcriptional behavior of DMD gene duplications in DMD/BMD males 121
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 121
Autosomal recessive Bethlem myopathy 120
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 118
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 116
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 113
null 113
Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy 113
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 113
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 112
Custom CGH array profiling of copy number variations (CNVs) on chromosome 6p21.32 (HLA locus) in patients with venous malformations associated with multiple sclerosis 108
Prenatal diagnosis of Duchenne muscular dystrophy by comparative genomic hybridization 107
Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 107
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 104
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 93
EM.P.4.07 Autosomal recessive Bethlem myopathy 91
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 87
null 86
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair 78
Studio di CNVs nel locus HLA (6p21.32) mediante Array CGH in pazienti con Sclerosi Multipla e malformazioni venose 75
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 70
Exploiting The CRISPR/CAS9 System to Study Alternative Splicing In Vivo: Application to titin 66
Transcriptional enhancement as therapeutic approach of coagulation factor VII promoter mutations 64
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 63
MOLECULAR MECHANISMS AND THERAPEUTIC APROACHES FOR RESTORATION OF mRNA TRANSCRIPTION, MATURATION AND TRANSLATION IN INHERITED COAGULATION FACTOR DEFICIENCIES 61
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 57
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 55
Conjugates of oligonucleotides and bile acids and their derivatives for pharmaceutical active molecules delivery 49
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 37
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 35
Synthesis and exon‐skipping properties of a 3′‐ursodeoxycholic acid‐conjugated oligonucleotide targeting dmd pre‐mrna: Pre‐synthetic versus post‐ synthetic approach 34
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 33
A new rat model for Duchenne muscular dystrophy generated by CRISPR-induced deletion of Exon 45 31
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 29
Efficient generation of mouse models with the CRISPR/Cas9 technology 28
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 27
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 26
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 23
G.P.3.02 In vivo biodistribution of non-viral systems for oligoribonucleotides delivery 23
Targeted Genome Editing in Spinal Muscular Atrophy 16
Correction of exon 2, exon 2–9 and exons 8–9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system 10
Totale 7.217
Categoria #
all - tutte 33.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020766 0 0 0 0 0 182 138 124 112 120 45 45
2020/20211.053 99 69 75 125 53 75 90 99 52 139 121 56
2021/2022746 41 55 47 37 33 35 67 38 31 62 86 214
2022/2023812 75 82 8 111 154 93 52 63 85 11 44 34
2023/2024435 35 47 37 10 35 97 10 30 10 5 12 107
2024/2025745 41 30 158 119 254 143 0 0 0 0 0 0
Totale 7.217